كل ما تود معرفته عن BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Pete Reynolds

Politics

Ukraine: the war that shook the world

23 February 2026

The conflict has forced Russia to scale back its global footprint and NATO to boost its defence spending. Meanwhile, China and Middle powers have emerged as key beneficiaries.

Christopher Phillips

Reuters / Al Majalla

Politics

Trump has few good options on Iran

16 February 2026

As the US and Iran head to talks in Geneva, competing forces are pulling Trump in opposite directions. There are only two "good" scenarios in front of him, and neither will be easy to achieve.

Michael Horowitz

Reuters / Al Majalla

Business & Economy

Donald Trump answers a Supreme Court rebuke with new tariff threats

21 February 2026

The immediate economic impact will be more uncertainty

The Economist

Reuters-Al Majalla

Politics

Ex-Prince Andrew's arrest rocks the British monarchy

20 February 2026

His arrest is the first for a British royal in modern history and comes after it was revealed he had passed confidential state documents to US financier and sex offender Jeffrey Epstein

Con Coughlin

Aliaa Aboukhaddour

Culture & Social Affairs

The Kuwaiti collector preserving Fairuz's legacy

16 February 2026

Faris Al-Muhanna dreams of one day creating a digital archive to safeguard the history and memory of Lebanon's most iconic artist for future generations

Charbel Khoury

Sections

Regions

More

LATEST ISSUE

BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

Ukraine: the war that shook the world

Trump has few good options on Iran

Donald Trump answers a Supreme Court rebuke with new tariff threats

Ex-Prince Andrew's arrest rocks the British monarchy

The Kuwaiti collector preserving Fairuz's legacy

OPINIONS

Renewables on track to redefine global energy

Gulf economies are leaning less on oil

Iran’s strategy for war with the US

Huckabee's 'they could take it all' statement enrages Arabs

BioNTech

Sign up for the Weekly Newsletter